Molecular Chaperones’ Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis
Open Access
Abstract
Amyotrophic lateral sclerosis (ALS) is a neuronal degenerative condition identified via a build-up of mutant aberrantly folded proteins. The native folding of polypeptides is mediated by molecular chaperones, preventing their pathogenic aggregation. The mutant protein expression in ALS is linked with the entrapment and depletion of chaperone capacity. The lack of a thorough understanding of chaperones’ involvement in ALS pathogenesis presents a significant challenge in its treatment. Here, we review how the accumulation of the ALS-linked mutant FUS, TDP-43, SOD1, and C9orf72 proteins damage cellular homeostasis mechanisms leading to neuronal loss. Further, we discuss how the HSP70 and DNAJ family co-chaperones can act as potential targets for reducing misfolded protein accumulation in ALS. Moreover, small HSPB1 and HSPB8 chaperones can facilitate neuroprotection and prevent stress-associated misfolded protein apoptosis. Designing therapeutic strategies by pharmacologically enhancing cellular chaperone capacity to reduce mutant protein proteotoxic effects on ALS pathomechanisms can be a considerable advancement. Chaperones, apart from directly interacting with misfolded proteins for protein quality control, can also filter their toxicity by initiating strong stress-response pathways, modulating transcriptional expression profiles, and promoting anti-apoptotic functions. Overall, these properties of chaperones make them an attractive target for gaining fundamental insights into misfolded protein disorders and designing more effective therapies against ALS.Keywords
Funding Information
- Anusandhan National Research Foundation (EMR/2016/000716, 54/14/16/2020)
- Government of India (EMR/2016/000716, 54/14/16/2020)
This publication has 234 references indexed in Scilit:
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- Misfolded protein aggregates: Mechanisms, structures and potential for disease transmissionSeminars in Cell & Developmental Biology, 2011
- Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathyProtein & Cell, 2011
- Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALSNeuron, 2010
- Activation of Gene Transcription by Heat Shock Protein 27 May Contribute to Its Neuronal ProtectionJournal of Biological Chemistry, 2009
- TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase ToxicityJournal of Biological Chemistry, 2009
- Nucleoporins Prevent DNA Damage Accumulation by Modulating Ulp1-dependent Sumoylation ProcessesMolecular Biology of the Cell, 2007
- Structure, function, property, and role in neurologic diseases and other diseases of the sHsp22Journal of Neuroscience Research, 2007
- The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperonesCellular and Molecular Life Sciences, 2006
- Modulation of neurodegeneration by molecular chaperonesNature Reviews Neuroscience, 2005